198 related articles for article (PubMed ID: 24715544)
1. Multi-institutional retrospective study for the evaluation of ocular function-preservation rates in maxillary sinus squamous cell carcinomas with orbital invasion.
Sakashita T; Hayashi R; Homma A; Matsuura K; Kato K; Kawabata K; Monden N; Hasegawa Y; Onitsuka T; Fujimoto Y; Iwae S; Okami K; Matsuzuka T; Yoshino K; Fujii M
Head Neck; 2015 Apr; 37(4):537-42. PubMed ID: 24715544
[TBL] [Abstract][Full Text] [Related]
2. Management of the orbital contents in radical surgery for squamous cell carcinoma of the maxillary sinus.
Wu X; Tang P; Qi Y
Chin Med J (Engl); 1995 Feb; 108(2):123-5. PubMed ID: 7774386
[TBL] [Abstract][Full Text] [Related]
3. Results of orbital preservation for advanced malignant maxillary sinus tumors.
Nishino H; Ichimura K; Tanaka H; Ishikawa K; Abe K; Fujisawa Y; Shinozaki T
Laryngoscope; 2003 Jun; 113(6):1064-9. PubMed ID: 12782824
[TBL] [Abstract][Full Text] [Related]
4. [Management in squamous cell carcinoma of maxillary sinus with orbital invasion].
Hu Y; Zhou L; Huang W; Gu Y; Ni R; Li X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Oct; 20(20):937-8. PubMed ID: 17225524
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary therapy consisting of minimally invasive resection, irradiation, and intra-arterial infusion of 5-fluorouracil for maxillary sinus carcinomas.
Nishino H; Takanosawa M; Kawada K; Kanazawa T; Ichimura K; Takahashi S; Nakazawa M
Head Neck; 2013 Jun; 35(6):772-8. PubMed ID: 22730109
[TBL] [Abstract][Full Text] [Related]
6. Orbital preservation in maxillectomy.
Stern SJ; Goepfert H; Clayman G; Byers R; Wolf P
Otolaryngol Head Neck Surg; 1993 Jul; 109(1):111-5. PubMed ID: 8336956
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
8. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
9. The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2767-70. PubMed ID: 24213278
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma.
Shiga K; Yokoyama J; Hashimoto S; Saijo S; Tateda M; Ogawa T; Watanabe M; Kobayashi T
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):1003-9. PubMed ID: 17547996
[TBL] [Abstract][Full Text] [Related]
11. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
Chen NX; Chen L; Wang JL; Wang JY; Yan F; Ma L; Zhang XX
Jpn J Clin Oncol; 2016 Aug; 46(8):727-34. PubMed ID: 27207888
[TBL] [Abstract][Full Text] [Related]
12. Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
Yasumatsu R; Nakashima T; Sato M; Nakano T; Kogo R; Hashimoto K; Sawatsubashi M; Nakagawa T
Auris Nasus Larynx; 2017 Feb; 44(1):98-103. PubMed ID: 27108101
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
[TBL] [Abstract][Full Text] [Related]
14. Studies of the anatomy and pathology of the orbit in carcinoma of the maxillary sinus and their impact on preservation of the eye in maxillectomy.
Tiwari R; van der Wal J; van der Waal I; Snow G
Head Neck; 1998 May; 20(3):193-6. PubMed ID: 9570623
[TBL] [Abstract][Full Text] [Related]
15. [Is orbital exenteration indicated for extensive primary mucosal melanomas of the sinunasal system?].
Hölzl M; Stölzel K; Schrom T; Scherer H; Lammert I
Laryngorhinootologie; 2007 May; 86(5):346-51. PubMed ID: 17226435
[TBL] [Abstract][Full Text] [Related]
16. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
[TBL] [Abstract][Full Text] [Related]
17. Survival Outcomes for Induction vs Adjuvant Chemotherapy in Squamous Cell Carcinoma of the Maxillary Sinus.
Kuo P; Torabi SJ; Kraus D; Judson BL
Otolaryngol Head Neck Surg; 2019 Apr; 160(4):658-663. PubMed ID: 30296902
[TBL] [Abstract][Full Text] [Related]
18. Impact of superselective transarterial infusion therapy of high-dose cisplatin on maxillary cancer with orbital invasion.
Kanoto M; Oda A; Hosoya T; Nemoto K; Ishida A; Nasu T; Koike S; Aoyagi M
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1390-4. PubMed ID: 20360344
[TBL] [Abstract][Full Text] [Related]
19. Cerebral infarction after intraarterial and intravenous chemoradiotherapy for head and neck cancer: A retrospective analysis using a Japanese inpatient database.
Suzuki S; Yasunaga H; Matsui H; Fushimi K; Saito Y; Yamasoba T
Head Neck; 2016 Sep; 38(9):1354-8. PubMed ID: 27015638
[TBL] [Abstract][Full Text] [Related]
20. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
